SEC Comment Letter for Century Therapeutics, (IPSC) — Jul 14, 2025
Century Therapeutics, Inc.
Date: July 14, 2025 · CIK: 0001850119 · Accession: 0000000000-25-007410
AI Filing Summary & Sentiment
File numbers found in text: 333-288616
Letter
July 14, 2025 Brent Pfeiffenberger President and Chief Executive Officer Century Therapeutics, Inc. 25 North 38th Street, 11th Floor Philadelphia, PA 19104 Re:Century Therapeutics, Inc. Registration Statement on Form S-3 Filed July 10, 2025 File No. 333-288616 Dear Brent Pfeiffenberger: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Justin Platt, Esq.
Show Raw Text
July 14, 2025
Brent Pfeiffenberger
President and Chief Executive Officer
Century Therapeutics, Inc.
25 North 38th Street, 11th Floor
Philadelphia, PA 19104
Re:Century Therapeutics, Inc.
Registration Statement on Form S-3
Filed July 10, 2025
File No. 333-288616
Dear Brent Pfeiffenberger:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Justin Platt, Esq.